Imatinib is a small-molecule inhibitor of multiple tyrosine kinases, including ABL, c-KIT, and PDGFR-β. It is primarily used as an active pharmaceutical ingredient in targeted cancer therapy.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 152459-95-5
Imatinib mesylate
pharmaceutical raw material
N-Desmethyl N-Nitroso Imatinib
research compound
Cgp-74588
pharmaceutical raw material
4-[(4-Methyl-4-oxo-4λ⁵-piperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide
pharmaceutical raw material
Oxytetracycline hemicalcium salt
pharmaceutical raw material
(S,R,R,R)-nebivolol hydrochloride
pharmaceutical raw material
Trans-tramadol
pharmaceutical raw material
A-65297
pharmaceutical raw material
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
KTUFNOKKBVMGRW-UHFFFAOYSA-N
CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5